Amos Michelson is the founder of Kardium. Kardium has raised $215M in total funding. Latest round: Growth. Based in Vancouver, Canada.
Amos Michelson is a co-founder of Kardium, a British Columbia-based medical device company that develops advanced systems for treating atrial fibrillation, a common heart disorder. Kardium secured $115 million USD from Fidelity Management and T. Rowe Price Associates, with T. Rowe Price Associates previously leading a $40 million USD financing round in 2018. Before Kardium, Michelson, along with Daniel Gelbart and Doug Goertzen, worked at digital imaging company Creo Inc., which was acquired in 2005.
Full founder directory · Investor directory · Company funding database · Fundraising library